ETF (UCITS compliant)

L&G Healthcare Breakthrough UCITS ETF

Fund facts

Fund size*
Base currency
Listing date
Index ticker
Replication method
Physical - full replication


*As at 05 März 2021

Fund aim

Der L&G Healthcare Breakthrough UCITS ETF (der „ETF“) soll die Wertentwicklung des ROBO Global® Healthcare Technology and Innovation Index TR (der „Index“) abbilden.

  • Langfristige Allokation

Es handelt sich um einen langfristigen Megatrend, der unseres Erachtens unsere Lebens- und Arbeitswelt radikal verändern wird

  • Hohes Wachstumspotenzial

Ziel ist es, das außerordentliche Wachstumspotenzial der Gesundheitstechnologiebranche auszuschöpfen

  • Branchenexpertise nutzen

Eine indexabbildende Anlagestrategie, die von einem Team von Experten für Gesundheitstechnologie unterstützt wird

ROBO Global® Healthcare Technology and Innovation Index TR

Der Index soll die Wertentwicklung einer Zusammensstellung von Unternehmen abbilden, die aktiv in der Wertschöpfungskette der Gesundheitstechnologiebranche tätig sind.

Der Index setzt sich aus Unternehmen zusammen, die an verschiedenen Börsen der Welt öffentlich gehandelt werden und zu einem großen Teil im Bereich der Gesundheitstechnologie tätig sind, einen wesentlichen Teil ihres Umsatzes in diesem Bereich erwirtschaften und über das Potenzial verfügen, durch Innovation und/oder Marktadoption ihrer Produkte/Dienstleistungen in dieser Branche weiter zu wachsen. Die im Index enthaltenen Unternehmen erhalten einen sogenannten „HTEC Score“, aus dem hervorgeht (1) wie hoch ihr Umsatz aus innovativen Gesundheitstechnologien ist, (2) wie viel sie in Gesundheitstechnologien investieren und (3) inwiefern sie bei den Technologien und auf dem Markt im Allgemeinen eine Führungsposition innehaben.

Ein Unternehmen wird nur in den Index aufgenommen, wenn es (1) ausreichend groß (gemessen am Gesamtmarktwert seiner Aktien) und (2) ausreichend liquid ist (was daran gemessen wird, wie aktiv seine Aktien täglich gehandelt werden). Innerhalb des Index sind die Unternehmen anhand einer modifizierten HTEC-Faktorengewichtung gewichtet. Der Index wird vierteljährlich neu ausgerichtet, namentlich im März, im Juni, im September und im Dezember.

Index data

ROBO Global®
Bloomberg code
Reuters code
Total Return


Source: Lipper.

Performance (%)
Select period:

    Performance summary (%)

    As at 31 Jan 2021

    1 month8,088,13
    6 months40,0440,41
    Year to date8,088,13
    3 years--
    5 years--
    Since launch96,0297,65
    1 year77,6078,47
    3 years--
    5 years--
    Since launch52,0853,08

    As at 31 Dec 2020

    Year to date65,7266,55
    3 years--
    5 years--
    Since launch81,3782,78
    1 year65,4966,31
    3 years--
    5 years--
    Since launch47,9248,68
    Rolling 12-month performance
    Calendar year performance
    Monthly performance
    Annualised performance

    Rolling 12-month performance to last quarter end (%)

    12 months to 31 Dezember 2016 2017 2018 2019 2020

    Calendar year performance (%)

    2016 2017 2018 2019 2020

    Monthly performance (%)

    Annualised performance (%)

    1 year3 years5 yearsSince launch

    Annualised performance (%)

    1 year3 years5 yearsSince launch

    Performance for the USD Accumulating ETF class in USD, listed on 02 July 2019. Source: Lipper. Performance assumes all ETF charges have been taken and that all income generated by the investments, after deduction of tax, remains in the ETF.

    Past performance is not a guide to the future.


    As at 31 Jan 2021. All data source LGIM unless otherwise stated. Totals may not sum to 100% due to rounding.

    The breakdowns below relate to the Index. The ETF’s portfolio may deviate from the below

    Sector (%)

    Medical Instruments28.3
    Process Automation12.2
    Precision Medicine12.2
    Data Analytics9.6
    Regenerative Medicine4.2

    Currency (%)

    Top 10 constituents19.7
    Rest of Index80.4
    No. of constituents in Index82

    Top 10 constituents (%)

    Fulgent Genetics3.0
    3D Systems2.7
    Editas Medicine2.3
    Tabula Rasa HealthCare1.9
    1Life Healthcare1.6
    Glaukos Corp1.6
    Health Catalyst1.6
    Vocera Communications1.6
    STAAR Surgical1.6

    Investment Manager

    GO ETF Solutions LLP is the investment manager for each of the exchange traded funds (ETFs) issued by Legal & General UCITS ETF Plc and is responsible for the day-to-day investment management decisions for this ETF. The team is highly experienced with respect to all aspects relating to the management of an ETF portfolio, including collateral management, OTC swap trading, adherence to UCITS regulations and counterparty exposure and monitoring.



    USD Acc
    Price time

    Further details



    Management / administration

    Legal & General UCITS ETF Plc
    Depositary and Trustee
    The Bank of New York Mellon SA/NV, Dublin Branch
    Securities regulator
    Central Bank of Ireland

    Country registration

    This share class is registered for sale in the following countries:


    ExchangeCurrencyTickerListing dateISINBloomberg codeReuters codeTrading hours (local)
    Deutsche BörseEURXMLH10/09/2019IE00BK5BC677XMLH GYDOCT.DE09:00 - 17:30
    London Stock ExchangeGBPDOCG02/07/2019IE00BK5BC677DOCG LNDOCG.L08:00 - 16:30
    London Stock ExchangeUSDDOCT02/07/2019IE00BK5BC677DOCT LNDOCT.L08:00 - 16:30
    Borsa ItalianaEURDOCT10/09/2019IE00BK5BC677DOCT IMLGDOCT.MI09:00 - 17:30
    SIX Swiss ExchangeCHFDOCT05/06/2020IE00BK5BC677DOCT SWDOCT.S09:00 - 17:30

    Key risks

    The value of an investment and any income taken from it is not guaranteed and can go down as well as up. You may not get back the amount you originally invested.

    Past performance is not a guide to the future.

    For more information, please refer to the key investor information document.

    Important information

    In the United Kingdom and outside the European Economic Area, it is issued by Legal & General Investment Management Limited, authorised and regulated by the Financial Conduct Authority, No. 119272. Registered in England and Wales No. 02091894 with registered office at One Coleman Street, London, EC2R 5AA.

    In the European Economic Area, it is issued by LGIM Managers (Europe) Limited, authorised by the Central Bank of Ireland as a UCITS management company (pursuant to European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations, 2011 (S.I. No. 352 of 2011), as amended) and as an alternative investment fund manager with “top up” permissions which enable the firm to carry out certain additional MiFID investment services (pursuant to the European Union (Alternative Investment Fund Managers) Regulations 2013 (S.I. No. 257 of 2013), as amended). Registered in Ireland with the Companies Registration Office (No. 609677). Registered Office: 33/34 Sir John Rogerson’s Quay, Dublin, 2, Ireland. Regulated by the Central Bank of Ireland (No. C173733).

    LGIM Managers (Europe) Limited operates a branch network in the European Economic Area, which is subject to supervision by the Central Bank of Ireland. In Italy, the branch office of LGIM Managers (Europe) Limited is subject to limited supervision by the Commissione Nazionale per le società e la Borsa (“CONSOB”) and is registered with Banca d’Italia (no. 23978.0) with registered office at Via Uberto Visconti di Modrone, 15, 20122 Milan, (Companies’ Register no. MI - 2557936). In Germany, the branch office of LGIM Managers (Europe) Limited is subject to limited supervision by the German Federal Financial Supervisory Authority (“BaFin”). In the Netherlands, the branch office of LGIM Managers (Europe) Limited is subject to limited supervision by the Dutch Authority for the Financial Markets (“AFM“) and it is included in the register held by the AFM and registered with the trade register of the Chamber of Commerce under number 74481231. Details about the full extent of our relevant authorisations and permissions are available from us upon request.

    We are a member of the Irish Funds Association.

    All features described on this website are those current at the time of publication and may be changed in the future. Nothing on this website should be construed as advice and it is therefore not a recommendation to buy or sell securities. If in doubt about the suitability of this product, you should seek professional advice. Copies of the prospectus, key investor information document, annual and semi-annual reports & accounts are available free of charge on request or at

    This website is only directed at investors resident in jurisdictions where our funds are registered for sale. It is not an offer or invitation to persons outside of those jurisdictions. We reserve the right to reject any applications from outside of such jurisdictions.

    Source and third party data

    Source: Unless otherwise indicated all data contained on this website is sourced from Legal & General Investment Management Limited.

    Where this document contains third party data ('Third Party Data’), we cannot guarantee the accuracy, completeness or reliability of such Third Party Data and accept no responsibility or liability whatsoever in respect of such Third Party Data

    Index disclaimer

    The L&G Healthcare Breakthrough UCITS ETF (the “ETF”) is not sponsored, promoted, sold or supported in any other manner by ROBO Global LLC or Solactive AG (the “Index Parties”), nor do the Index Parties offer any express or implicit guarantee or assurance either with regard to the results of using the ROBO Global® Healthcare Technology and Innovation Index (the “Index”) and/or Index trademark or the Index price at any time or in any other respect. The Index is calculated and published by Solactive AG. The Index Parties use their best efforts to ensure that the Index is calculated correctly. Irrespective of their obligations towards the Company, the Index Parties have no obligation to point out errors in the Index to third parties including but not limited to investors and/or financial intermediaries of the ETF. Neither publication of the Index by Solactive AG nor the licensing of the Index or Index trademark by ROBO Global LLC for the purpose of use in connection with the ETF constitutes a recommendation by the Index Parties to invest capital in the ETF nor does it in any way represent an assurance or opinion of the Index Parties with regard to any investment in the ETF.